klp 6_farmakoterapi ii bronkitis & pneumonia
TRANSCRIPT
BRONCHITISGRUP 6 Farmakoterapi II kelas A
1. Melisa Amir2. Nur Asma3. Nur Irjawati S.K4. Muti Purnama S.5. Ananda Lisda P.
FAKULTAS FARMASIUNIVERSITAS HASANUDDIN
DEFINITION
Pharmacotherapy handbook page : 465
CLASSIFICATION
Bronchitis
Acute bronchitis
Chronic Bronchitis
ACUTE BRONCHITIS
Acute bronchitis most commonly occurs during the winter months. Cold, damp climates and/or the presence of high concentrations of irritating substances such as air pollution or cigarette smoke may precipitate attacks.
Pharmacotherapy handbook page : 465
Pathophysiology
Pharmacotherapy handbook page : 465
Clinical Presentation
Desired Outcome
The goals of therapy are to provide comfort to the patient and, in the unusually severe case, to treat associated dehydration and respiratory compromise
Treatment
Treatment
CHRONIC BRONCHITIS
Chronic bronchitis is defined clinically as a chronic productive cough for at least 3 months in each of two consecutive years in a patient in whom other causes have been excluded
Pharmacotherapy principles & practice page : 272
Pathophysiology
Pictures
Clinical Presentation
Clinical Presentation
Clinical Presentation
Clinical Presentation
Clinical Presentation
Desired Outcome
The goals of therapy for chronic bronchitis are to reduce the severity of symptoms, to ameliorate acute exacerbations, and to achieve prolonged infection-free intervals.
Treatment
Treatment
Treatment
PNEUMONIA
DEFINITION
Pharmacotherapy handbook page : 471
Pneumonia is the most common infectious cause of death in the United States. It occurs in persons of all ages, although the clinical manifestations are most severe in the very young, the elderly, and the chronically ill.
Pathophysiology
Pharmacotherapy handbook page : 465
Pathophysiology
Clinical Presentation
Gram-Positive and Gram-Negative Bacterial Pneumonia
Anaerobic Pneumonia
Mycoplasma pneumoniae
Viral Pneumonia
Nosocomial Pneumonia
Clinical PresentationGram-Positive and Gram Negative Bacterial
Pneumonia
BACK
Clinical PresentationAnaerobic Pneumonia
BACK
Clinical PresentationMycoplasma Pneumonia
BACK
Clinical PresentationMycoplasma Pneumonia
BACK
Clinical PresentationViral and Nosocomial Pneumonia
BACK
Desired Outcome
Eradication of the offending organism and complete clinical cure are the primary objectives. Associated morbidity should be minimized (e.g, renal pulmonary, or hepatic dysfunction))
TreatmentTHERAPY FOR ADULTS
TreatmentTHERAPY FOR PEDIATRIC
Treatment with Antibiotic for Bacterial Pneumonia
Treatment
EVALUATION OF THERAPEUTIC OUTCOMES
THANK YOU
WASSALAMUALAIKUM WARAHMATULLAHI WABARAKATUH